<p>Note: A risk assessment and treatment strategy is said to dominate if it is less costly and more effective than both of the alternative strategies to which it is compared. Otherwise, the favored strategy may be incrementally more costly and more effective than ATP III, which was the standard of risk assessment when this study was conducted. If the incremental cost per unit of effect is less than or equal to $50,000, the alternative intervention is assumed to be favored, and an incremental cost-effectiveness ratio (ICER) is reported. If the ICER exceeds $50,000, but is positive, then ATP III is preferred. Mean costs and effects for each scenario, which are the basis for the decisions summarized in the table, are presented in <a href="http...
<p>Threshold analysis: Incremental cost-effectiveness ratio (ICER) versus price of IIV4.</p
A univariable sensitivity analysis of the ICER for different parameters over the range for each para...
<p>(A) Scatter plot of incremental cost and incremental effectiveness per person of ≥65 PPSV–23 stra...
<p>The analysis uses 1,000 non-homogeneous Markov-Chain Monte Carlo simulations of 1,000 patients fo...
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
<p>Event rates adjusted for the level of INR monitoring, incremental costs, QALYs and ICERs.</p><p>I...
<p><sup>a</sup>ICER = Incremental Cost- Effectiveness Ratio</p><p><sup>b</sup> Ranges obtained from ...
<p>Incremental costs of ABT vs. EPO strategy – Sensitivity Analyses: Most Influential Parameters (Fa...
<p>Abbreviations: ICER, incremental cost effectiveness ratio, which is the difference in cost divide...
<p>. Selected model parameters are listed on the vertical axis, with the range examined in sensitivi...
<p><sup></sup> The effect of assumptions on the ICER of Xpert-for-all compared to triage pathway wit...
<p>Tornado graph showing results of one-way sensitivity analysis derived from probabilistic method. ...
<p>. Major toxicity associated with 6EH, percent cohort completion of the regimen, and efficacy of t...
<p>All costs in US dollars. Incremental cost-effectiveness thresholds obtained in one-way sensitivit...
<p>All model parameters were analyzed, and only those with the highest relative effect on ICER are d...
<p>Threshold analysis: Incremental cost-effectiveness ratio (ICER) versus price of IIV4.</p
A univariable sensitivity analysis of the ICER for different parameters over the range for each para...
<p>(A) Scatter plot of incremental cost and incremental effectiveness per person of ≥65 PPSV–23 stra...
<p>The analysis uses 1,000 non-homogeneous Markov-Chain Monte Carlo simulations of 1,000 patients fo...
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
<p>Event rates adjusted for the level of INR monitoring, incremental costs, QALYs and ICERs.</p><p>I...
<p><sup>a</sup>ICER = Incremental Cost- Effectiveness Ratio</p><p><sup>b</sup> Ranges obtained from ...
<p>Incremental costs of ABT vs. EPO strategy – Sensitivity Analyses: Most Influential Parameters (Fa...
<p>Abbreviations: ICER, incremental cost effectiveness ratio, which is the difference in cost divide...
<p>. Selected model parameters are listed on the vertical axis, with the range examined in sensitivi...
<p><sup></sup> The effect of assumptions on the ICER of Xpert-for-all compared to triage pathway wit...
<p>Tornado graph showing results of one-way sensitivity analysis derived from probabilistic method. ...
<p>. Major toxicity associated with 6EH, percent cohort completion of the regimen, and efficacy of t...
<p>All costs in US dollars. Incremental cost-effectiveness thresholds obtained in one-way sensitivit...
<p>All model parameters were analyzed, and only those with the highest relative effect on ICER are d...
<p>Threshold analysis: Incremental cost-effectiveness ratio (ICER) versus price of IIV4.</p
A univariable sensitivity analysis of the ICER for different parameters over the range for each para...
<p>(A) Scatter plot of incremental cost and incremental effectiveness per person of ≥65 PPSV–23 stra...